| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ... Research Square, 2021 | 79 | 2021 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 32 | 2024 |
| Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022 J Bingham, R Cable, C Coleman, TN Glatt, E Grebe, L Mhlanga, C Nyano, ... Research square, 2022 | 27 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 18 | 2024 |
| Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021 R Cable, C Coleman, T Glatt, E Grebe, L Mhlanga, C Nyoni, N Pieterson, ... Research Square, 2022 | 13 | 2022 |
| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa during the period January-May 2021 M Vermeulen, L Mhlanga, W Sykes, C Coleman, N Pietersen, R Cable, ... | 12 | 2021 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 4 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 4 | 2024 |
| The role of wastewater-based epidemiology for SARS-CoV-2 in developing countries: Cumulative evidence from South Africa supports sentinel site surveillance to guide public … C Iwu-Jaja, NL Ndlovu, S Rachida, M Yousif, S Taukobong, M Macheke, ... Science of The Total Environment 903, 165817, 2023 | 3 | 2023 |
| SARS CoV 2 Infection Fatality Rate Estimates for South Africa L Mhlanga, M Vermeulen, E Grebe, A Welte | 3 | 2021 |
| Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 JR Ledesma, J Ma, M Zhang, AVL Basting, HT Chu, A Vongpradith, ... The Lancet Infectious Diseases, 2024 | 2 | 2024 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases, 2024 | 1 | 2024 |
| Evidence of HIV incidence reduction in young women, but not in adolescent girls, in KwaZulu-Natal, South Africa L Mhlanga, A Welte, E Grebe, L Ohler, G Van Cutsem, H Huerga, ... IJID regions 8, 111-117, 2023 | 1 | 2023 |
| The added value of recent-infection testing in population-based HIV surveys L Mhlanga, E Grebe, A Welte | 1 | 2021 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 V Stein Emil, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... Elsevier, 2024 | | 2024 |
| Coproduction of a mixed-method framework for the deprioritization of communities during insecticide-treated bed net mass campaigns in Kwara Nigeria I Ozodiegwu, L Mhlanga, E Bamgboye, A Fagbamigbe, C Ademu, ... | | 2024 |
| The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves M Vermeulen, L Mhlanga, W Sykes, R Cable, C Coleman, N Pietersen, ... Vox Sanguinis 119 (3), 242-251, 2024 | | 2024 |
| Global Burden of Cardiovascular Diseases and Risks, 1990-2022 M George A, V Fuster, CJL Murray, GA Roth, GA Mensah, YH Abate, ... Elsevier, 2023 | | 2023 |
| P‐PH‐8| The Evolution and Interpretation of Seroprevalence of SARS‐CoV‐2 Antibodies Among Blood Donors from the Beta to Omicron Variant Driven Waves M Vermeulen, W Sykes, K van den Berg, R Cable, C Coleman, T Glatt, ... Transfusion 63, 236A-237A, 2023 | | 2023 |
| Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022 (preprint) J Bingham, R Cable, C Coleman, TN Glatt, E Grebe, L Mhlanga, C Nyano, ... | | 2022 |
Alex WelteStellenbosch UniversityVerified email at sun.ac.za
